Blincyto is a bispecific CD19-directed CD3 T-cell engager approved by the US FDA for the treatment of both adults and children with:
B-cell precursor ALL (type of cancer of the blood and bone marrow that impacts WBCs) in first or second complete remission (CR) with minimal residual disease (MRD) beyond or equal to 0.1 %.
Relapsed or difficult to treat or cure B-cell precursor acute lymphoblastic leukemia (ALL).
This medicinal product is commercially available in 38.5 mcg & 35 mcg dosage strengths for intravenous (IV) use or administration. The exact cost of Blincyto in India may vary, as this medication is not readily accessible in India. Blincyto contains the active salt Blinatumomab. This medicinal product has also been approved by the EU (European Union).
Price of Blincyto in India:
Blincyto (Blinatumomab) is not (yet) approved or registered in India by respective authorities. This drug for ALL is not easily available. Blincyto injection price is not fixed by the respective authorities because it is yet to be registered/approved in India. It is believed that quantity of procurement also plays a crucial role in Blincyto cost dynamics. Trusted service providers like THE INDIAN PHARMA (TIP) can offer the best price of Blincyto in India and other countries where this medicine is not (yet) approved/registered.
Who to Contact to Buy Blincyto:
To buy Blincyto online in India, one can approach a trustworthy provider with extensive experience in importing Blincyto injections through legal channels. Patients, Physicians, or Hospitals can connect with THE INDIAN PHARMA (TIP) either via Call or WhatsApp: +91 9310090915 or dial our TOLL-FREE Number: 1800-889-1064.
Reference:
Comments